首页 | 本学科首页   官方微博 | 高级检索  
检索        

Ⅱ~Ⅳ期乳腺癌患者中Panagen激活继发性免疫反应和白细胞活性的Ⅱ期多中心双盲安慰剂对照临床研究
引用本文:欧阳取长,胡哲煜,朱文珍.Ⅱ~Ⅳ期乳腺癌患者中Panagen激活继发性免疫反应和白细胞活性的Ⅱ期多中心双盲安慰剂对照临床研究[J].循证医学,2018,18(3):140-143.
作者姓名:欧阳取长  胡哲煜  朱文珍
作者单位:1. 湖南省肿瘤医院乳腺内科,长沙 410013; 2. 广东省人民医院肿瘤中心乳腺科、广东省医学科学院, 广州510080
摘    要:

关 键 词:乳腺癌  Panagen  适应性免疫  白细胞  

Results of Multicenter Double-Blind Placebo-Controlled PhaseⅡ Clinical Trial of Panagen Preparation to Evaluate Its Leukostimulatory Activity and Formation of The Adaptive Immune Response in Patients with Stage Ⅱ~ⅣBreast Cancer
OUYANG Qu-chang,HU Zhe-yu,ZHU Wen-zhen.Results of Multicenter Double-Blind Placebo-Controlled PhaseⅡ Clinical Trial of Panagen Preparation to Evaluate Its Leukostimulatory Activity and Formation of The Adaptive Immune Response in Patients with Stage Ⅱ~ⅣBreast Cancer[J].The Journal of Evidence-Based Medicine,2018,18(3):140-143.
Authors:OUYANG Qu-chang  HU Zhe-yu  ZHU Wen-zhen
Institution:Reviewer's address: Department of Breast Cancer Medical Oncology, Hu'nan Cancer Hospital, Changsha 410013, China
Abstract:
Keywords:breast cancer  Panagen  adaptive immune  leukocytel  
点击此处可从《循证医学》浏览原始摘要信息
点击此处可从《循证医学》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号